Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
It is not an FDA-approved drug for systemic therapeutic use
Individual results may vary, and the safety of BPC-157 for human use has not been established through clinical trials.
Radiofrequency (RF) Skin Tightening: RF treatments heat deep layers of skin to stimulate natural collagen production , improving elasticity and tightening loose skin around the abdomenideal for post-pregnancy or post-weight loss skin laxity
A separate Phase 2 trial in type 2 diabetes evaluated retatrutide against placebo and an active comparator, reporting clinically meaningful reductions in HbA1c together with weight loss across the dose range
That distinction is important
